Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

AGH MESA LLC

NPI: 1124656376 · CHANDLER, AZ 85286 · Emergency Care Clinic/Center · NPI assigned 03/31/2020

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official HANSON, JANE controls 19+ related entities in our dataset. Read more

$1.12M
Total Medicaid Paid
17,376
Total Claims
16,549
Beneficiaries
35
Codes Billed
2022-06
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHANSON, JANE (PRESIDENT/CEO)
NPI Enumeration Date03/31/2020

Related Entities

Other providers sharing the same authorized official: HANSON, JANE

ProviderCityStateTotal Paid
AGH LAVEEN LLC LAVEEN AZ $109.33M
AGH MESA LLC MESA AZ $28.01M
AGH LAVEEN LLC GLENDALE AZ $14.88M
AGH MESA LLC MESA AZ $4.69M
AGH LAVEEN LLC GOODYEAR AZ $4.04M
AGH LAVEEN LLC SURPRISE AZ $3.48M
AGH LAVEEN LLC GLENDALE AZ $3.40M
AGH MESA LLC TEMPE AZ $3.34M
AGH MESA LLC CHANDLER AZ $2.76M
AGH MESA LLC MESA AZ $2.66M
AGH MESA LLC SAN TAN VALLEY AZ $2.32M
AGH MESA LLC PHOENIX AZ $1.74M
AGH MESA LLC GILBERT AZ $978K
AGH LAVEEN LLC MESA AZ $293K
AGH LAVEEN LLC CHANDLER AZ $259K
AGH LAVEEN LLC PHOENIX AZ $184K
AGH LAVEEN LLC MESA AZ $167K
AGH LAVEEN LLC GILBERT AZ $160K
AGH LAVEEN LLC CHANDLER AZ $41K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 3,299 $251K
2023 7,543 $479K
2024 6,534 $387K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 3,565 3,355 $620K
99284 Emergency department visit for the evaluation and management, high severity 1,483 1,415 $283K
99282 Emergency department visit for the evaluation and management, low to moderate severity 844 806 $76K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 173 169 $63K
74176 Computed tomography, abdomen and pelvis; without contrast material 53 52 $33K
74177 Computed tomography, abdomen and pelvis; with contrast material 38 37 $26K
70450 Computed tomography, head or brain; without contrast material 63 60 $14K
96375 Therapeutic injection; each additional sequential IV push 513 478 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 547 519 $546.12
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 772 735 $212.64
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 111 108 $82.10
87631 291 286 $61.07
80053 Comprehensive metabolic panel 1,004 944 $44.50
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,122 1,071 $37.19
96361 Intravenous infusion, hydration; each additional hour 28 27 $36.26
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 286 277 $31.19
71045 Radiologic examination, chest; single view 582 559 $27.65
71046 Radiologic examination, chest; 2 views 182 179 $27.47
J2405 Injection, ondansetron hydrochloride, per 1 mg 437 417 $18.30
J1885 Injection, ketorolac tromethamine, per 15 mg 847 810 $15.01
81025 544 525 $12.86
J7030 Infusion, normal saline solution , 1000 cc 816 760 $12.42
81003 666 640 $10.16
J1100 Injection, dexamethasone sodium phosphate, 1 mg 109 108 $9.29
84484 81 80 $0.00
36415 Collection of venous blood by venipuncture 1,223 1,165 $0.00
J3490 Unclassified drugs 40 40 $0.00
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 50 43 $0.00
87086 Culture, bacterial; quantitative colony count, urine 65 64 $0.00
82553 41 40 $0.00
87428 13 13 $0.00
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 217 210 $0.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 258 254 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 105 102 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 207 201 $0.00